EGFR and nasopharyngeal carcinoma: However, although epidermal growth factor receptor (EGFR) is overexpressed in NPC and is considered an important therapeutic target, retrospective studies showed that the therapeutic effect of the anti-EGFR drugs cetuximab (CTX) or nituzumab (NTZ) in combination with PCT is similar to that of PCT alone.